M. Okada

发表

Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors

Shigetada Nakanishi, S. Nakanishi, Tokio Yamaguchi, 1996, Nature.

Radioligand Binding Properties and Pharmacological Characterization of 6-Amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a High-Affinity, Selective, and Noncompetitive Antagonist of Metabotropic Glutamate Receptor Type 1

Seiji Tamura, Y. Shitaka, S. Kawabata, 2005, Journal of Pharmacology and Experimental Therapeutics.

Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models

Seiji Tamura, Shigeki Kawabata, Shigeki Kawabata, 2008, Brain Research.

The Metabotropic Glutamate Receptor mGluR5 Induces Calcium Oscillations in Cultured Astrocytes via Protein Kinase C Phosphorylation

S. Nakanishi, S. Nakanishi, K. Nakahara, 1997, Journal of neurochemistry.

Renoprotective properties of pirfenidone in subtotally nephrectomized rats.

A. Fujimori, M. Okada, Y. Iwatsuki, 2010, European journal of pharmacology.

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X(2/3) receptor function and exerts an analgesic effect in pain models.

M. Sasamata, M. Okada, S. Tamura, 2008, European journal of pharmacology.

Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats

H. Yamashita, Tokio Yamaguchi, M. Okada, 2004, Journal of Pharmacology and Experimental Therapeutics.

Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats

H. Yamashita, Tokio Yamaguchi, M. Okada, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.

S. Usuda, M. Okada, S. Sakamoto, 1996, The Journal of pharmacology and experimental therapeutics.

YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.

A. Kohara, Tokio Yamaguchi, M. Okada, 2006, CNS drug reviews.

Experimental model of lower limb ischemia in rats and the effect of YM466, an oral direct factor Xa inhibitor.

M. Okada, Y. Iwatsuki, T. Kawasaki, 2007, Biological & pharmaceutical bulletin.

Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy.

H. Yamashita, Tokio Yamaguchi, M. Okada, 2004, European journal of pharmacology.

8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.

M. Okada, S. Sakamoto, M. Shimizu‐Sasamata, 1997, Journal of medicinal chemistry.

Allodynia and Hyperalgesia in Adjuvant-Induced Arthritic Rats: Time Course of Progression and Efficacy of Analgesics

A. Kohara, Tokio Yamaguchi, M. Okada, 2003, Journal of Pharmacology and Experimental Therapeutics.

Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models.

H. Itahana, Y. Shitaka, A. Kohara, 2007, European journal of pharmacology.

6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor.

T. Furuya, K. Hidaka, M. Okada, 1994, Journal of medicinal chemistry.

Glutamate receptors: brain function and signal transduction 1 Published on the World Wide Web on 21 October 1997. 1

D. Watanabe, S. Nakanishi, S. Yamaguchi, 1998, Brain Research Reviews.

Effects of a New Thyrotropin Releasing Hormone Analogue, YM‐14673, on the In Vivo Release of Acetylcholine as Measured by Intracerebral Dialysis in Rats

M. Okada, M. Okada, 1991, Journal of neurochemistry.

ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".

Ken‐ichi Suzuki, M. Okada, T. Kawasaki, 2013, Thrombosis research.

Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.

M. Okada, S. Sakamoto, M. Shimizu‐Sasamata, 1996, Journal of medicinal chemistry.

Novel AMPA Receptor Antagonists: Synthesis and Structure-Activity Relationships of 1-Hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H) quinoxalinedione and Related Compounds.

M. Okada, S. Sakamoto, M. Shimizu‐Sasamata, 1997 .

Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionate Receptor Antagonists: Synthesis and Structure−Activity Relationships of 6-(1H-Imidazol-1-yl)- 7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and Related Compounds

M. Okada, H. Kubota, S. Sakamoto, 1996 .

Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionate Receptor Antagonists: Synthesis and Structure-Activity Relationships of 6-(1H- Imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido(2,3-b)pyrazinedione and Related Compounds.

M. Okada, H. Kubota, S. Sakamoto, 1996 .

In‐vitro Characterization of YM872, a Selective, Potent and Highly Water‐soluble α‐Amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionate Receptor Antagonist

R. Tsutsumi, A. Kohara, Tokio Yamaguchi, 1998, The Journal of pharmacy and pharmacology.

Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.

A. Kohara, M. Okada, T. Yamaguchi, 1996, European journal of pharmacology.

Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model

M. Okada, K. Terai, K. Mizukami, 2008, Nephrology.

Kainate excitotoxicity is mediated by AMPA- but not kainate-preferring receptors in embryonic rat hippocampal cultures

R. Tsutsumi, A. Kohara, Tokio Yamaguchi, 1997, Neurochemistry International.

Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures

N. Matsumoto, R. Tsutsumi, Tokio Yamaguchi, 1998, Neurochemistry International.

Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist

H. Yamashita, N. Matsumoto, R. Tsutsumi, 2003, Journal of Pharmacology and Experimental Therapeutics.

Functional Characterization of YM928, a Novel Noncompetitive AMPA Receptor Antagonist

N. Matsumoto, R. Tsutsumi, M. Okada, 2003 .

The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.

R. Tsutsumi, M. Okada, S. Sakamoto, 1998, Japanese journal of pharmacology.

8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.

M. Okada, S. Sakamoto, M. Shimizu‐Sasamata, 1997, Journal of medicinal chemistry.